ISMRM 21st Annual Meeting & Exhibition ○ 20-26 April 2013 ○ Salt Lake City, Utah, USA |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
TARGET AUDIENCE | |||||||||||||||||||||||||
This course is aimed at radiologists who wish to introduce new disease classifications, management strategies and techniques into their body MR practice. The course content will also be of interest to MR technologists and clinical support scientists involved in body MRI. | |||||||||||||||||||||||||
|
|||||||||||||||||||||||||
Tuesday, 23 April 2013 | |||||||||||||||||||||||||
OVERVIEW | |||||||||||||||||||||||||
Contrast-enhanced MR angiography (CE-MRA) allows assessment of vascular disorders non-invasively. With normal renal function, gadolinium-based contrast agents (GBCAs) are considered safe and can provide superb imaging of the arteries as well as the veins. Safety concerns in regard to the use of GBCAs in patients with renal dysfunction have once again focused attention on non-contrast MRA. This course will focus both on CE-MRA and non-contrast MRA to allow the attendees to become familiar with both methods to improve their clinical practice. | |||||||||||||||||||||||||
EDUCATIONAL OBJECTIVES Upon completion of this course, participants should be able to: |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
Body Vascular Imaging |
|||||||||||||||||||||||||
Moderator: Shahid M. Hussain, M.D., Ph.D. |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
Wednesday, 24 April 2013 | |||||||||||||||||||||||||
OVERVIEW | |||||||||||||||||||||||||
This one-hour course focuses on the correlation between the genotype and phenotype of various subtypes of liver cell adenoma and renal cell carcinoma, using a multiparametric approach. State-of-the-art techniques for evaluating the various subtypes of liver cell adenoma and renal cell carcinoma will be described. In addition, the clinical relevance of the different MR phenotypes will be highlighted. All lectures feature didactic-interactive lectures using audience response technology. | |||||||||||||||||||||||||
EDUCATIONAL OBJECTIVES Upon completion of this course, participants should be able to: |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
Genotype to Phenotype |
|||||||||||||||||||||||||
Moderators: Raj Mohan Paspulati, M.D. & Caroline Reinhold, M.D. |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
Thursday, 25 April 2013 | |||||||||||||||||||||||||
OVERVIEW | |||||||||||||||||||||||||
This one-hour course will review the MRI findings in cholangiocarcinoma and their surgical classification and management. The MRI findings and imaging techniques for cystic pancreatic lesions will be described, including an algorithmic approach to management of these lesions based on imaging findings and clinical context. | |||||||||||||||||||||||||
EDUCATIONAL OBJECTIVES Upon completion of this course, participants should be able to: |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
Biliary Tree & Pancreas |
|||||||||||||||||||||||||
Moderator: Masoom A. Haider, M.D., F.R.C.P.C. |
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||